COMMUNIQUÉ DE PRESSE publié le 06/02/2023 à 07:30, il y a 3 années 6 mois Aflibercept Biosimilar Candidate FYB203 shows comparable efficacy to the reference product Eylea®1 in Phase III Study
COMMUNIQUÉ DE PRESSE publié le 02/02/2023 à 08:00, il y a 3 années 6 mois Formycon and Fresenius Kabi conclude global commercialization partnership for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)
COMMUNIQUÉ DE PRESSE publié le 02/02/2023 à 07:30, il y a 3 années 6 mois EQS-Adhoc: Formycon AG announces result of private placement and sets placement price for the new shares from the capital increase
COMMUNIQUÉ DE PRESSE publié le 01/02/2023 à 23:30, il y a 3 années 6 mois EQS-Adhoc: Formycon AG upsizes capital increase from authorized capital following strong demand
COMMUNIQUÉ DE PRESSE publié le 01/02/2023 à 17:40, il y a 3 années 6 mois EQS-Adhoc: Formycon AG announces global license agreement with Fresenius Kabi for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)
COMMUNIQUÉ DE PRESSE publié le 01/02/2023 à 17:40, il y a 3 années 6 mois EQS-Adhoc: Formycon AG plans capital increase of approx. 5% of the share capital by way of an accelerated bookbuilding procedure to finance further growth
COMMUNIQUÉ DE PRESSE publié le 09/01/2023 à 13:05, il y a 3 années 7 mois EQS-Adhoc: Formycon announces binding Term Sheet between Klinge Biopharma and Coherus BioSciences for the exclusive commercialization of FYB203, a biosimilar candidate to Eylea®1, in the United States
Publié le 10/08/2026 à 11:53, il y a 3 heures 31 minutes GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Publié le 10/08/2026 à 11:53, il y a 3 heures 31 minutes GUILLEMOT CORPORATION |Informations relatives au nombre total de droits de vote et d’actions 31/07/2026
Publié le 10/08/2026 à 11:36, il y a 3 heures 48 minutes GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Publié le 10/08/2026 à 11:36, il y a 3 heures 48 minutes GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 3 au 7 août 2026
Publié le 10/08/2026 à 09:47, il y a 5 heures 37 minutes 260810 BENETEAU Transactions sur actions propres
Publié le 10/08/2026 à 14:30, il y a 55 minutes NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Publié le 10/08/2026 à 13:30, il y a 1 heure 55 minutes Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Publié le 10/08/2026 à 13:00, il y a 2 heures 25 minutes Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Publié le 10/08/2026 à 13:00, il y a 2 heures 25 minutes Azarga Metals Mobilizes Drill Rig and Ancillary Equipment to Marg Project, Yukon
Publié le 10/08/2026 à 13:00, il y a 2 heures 25 minutes NioCorp to Host Webcast on Aug. 11 to Discuss Elk Creek Feasibility Study Results
